Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 09, 2024 04:00 ET | Source: Novozymes A/S

Invitation to an extraordinary shareholders’ meeting of Novozymes A/S

An extraordinary shareholders’ meeting of Novozymes A/S will be held on Monday March 4, 2024 at 4:00 pm CET at Boege Alle 10-12, 2970 Hoersholm, Denmark. Attachments ...
February 08, 2024 13:52 ET | Source: Novozymes A/S

The Novozymes Report 2023

This annual report has been released subsequent to the approval of the combination of Novozymes and Chr. Hansen on January 29, 2024. The new combined group is called Novonesis. As an annual...
February 02, 2024 08:13 ET | Source: Novozymes A/S

Trading by management and close relations of management

Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and...
February 02, 2024 02:28 ET | Source: Novozymes A/S

Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed

Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed February 2, 2024Company announcement No. 07 On January 29, 2024, following the satisfaction of...
February 01, 2024 02:00 ET | Source: Novozymes A/S

Legacy Novozymes delivers solid last full-year results

Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks...
February 01, 2024 01:59 ET | Source: Novozymes A/S

Results update for 2023 – unaudited

6% organic sales growth in Q4 and 5% for the full year with solid margins and free cash flow generation As Novozymes just closed the combination with Chr. Hansen on January 29, and the annual...
January 31, 2024 08:20 ET | Source: Novozymes A/S

Total number of voting rights and capital on January 31, 2024

Total number of voting rights and capital on January 31, 2024 January 31, 2024Company announcement No. 05 Referring to company announcement 02, on January 29, 2024, where Novozymes A/S...
January 29, 2024 09:59 ET | Source: Novozymes A/S

Trading by management and close relations of management

January 29, 2024Company announcement No. 04 Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on...
January 29, 2024 07:13 ET | Source: Novozymes A/S

Major shareholder announcement

Major shareholder announcement January 29, 2024Company announcement No. 03 On January 29, 2024, following the satisfaction of all conditions precedent, the combination of...
January 29, 2024 05:27 ET | Source: Novozymes A/S

The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner

Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for...